ArticleBriefings in bioinformatics2026
GRAFT: a graph-aware fusion transformer for cancer driver gene prediction.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Disentangling Heterogeneous Molecular Networks for Multi-Omics-Driven Cancer Driver Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Identifying cancer driver genes is essential for precision oncology, but existing computational methods are often limited by their reliance on single biological networks and their inability to capture long-range molecular dependencies. To address these challenges, we propose GRAFT, a Graph-Aware Fusion Transformer. This framework learns modality-specific features from protein-protein interactions, pathway co-occurrence, and gene semantic similarity using a multi-view graph encoder. These representations are further enriched with two auxiliary feature types: structural encodings derived from network topology and functional embeddings guided by curated gene sets. The integrated features are then processed by a transformer backbone, where a novel edge-attention bias makes the model explicitly sensitive to the underlying graph topologies, enabling the effective modeling of both local and global dependencies. Extensive evaluations demonstrate that GRAFT achieves competitive performance with leading state-of-the-art methods in pan-cancer analysis, while consistently delivering superior predictive accuracy across numerous specific cancer types. More importantly, a functional enrichment analysis of the novel candidate driver genes predicted by our model confirms their strong associations with key cancer-related processes, demonstrating the model's ability to make biologically plausible discoveries. By delivering a powerful and interpretable framework, our model not only advances the identification of cancer driver genes but also establishes a robust paradigm for multimodal data integration in systems biology. The source codes and datasets are publicly accessible at https://github.com/spcho-dev/GRAFT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.